-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK: WEGOVY APPROVED IN CHINA AS THE FIRST AND ONLY GLP-1 RA FOR THE TREATMENT OF MASH

Reuters·09/10/2026 07:50:03

Please log in to view news